Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sulforaphane for Skin Fragility and Aging
NCT03126539Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Sep 2017
- Primary completion
- Jan 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sulforaphane in Skin aging, sponsored by Johns Hopkins University. Primary endpoint: Clinical Change Score for Mottled Hyperpigmentation at 1 week. Started Sep 2017; status: terminated.
02
Drugs
sulforaphane
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03126539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126539.